1. Home
  2. PNI vs OKYO Comparison

PNI vs OKYO Comparison

Compare PNI & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pimco New York Municipal Income Fund II of Beneficial Interest

PNI

Pimco New York Municipal Income Fund II of Beneficial Interest

N/A

Current Price

$7.02

Market Cap

77.8M

Sector

Finance

ML Signal

N/A

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

N/A

Current Price

$1.48

Market Cap

89.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PNI
OKYO
Founded
2002
2007
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.8M
89.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PNI
OKYO
Price
$7.02
$1.48
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
47.3K
53.7K
Earning Date
01-01-0001
07-18-2025
Dividend Yield
4.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.43
$1.42
52 Week High
$7.20
$3.35

Technical Indicators

Market Signals
Indicator
PNI
OKYO
Relative Strength Index (RSI) 57.66 37.50
Support Level $6.87 $1.48
Resistance Level $7.07 $1.73
Average True Range (ATR) 0.07 0.10
MACD 0.01 -0.02
Stochastic Oscillator 87.10 20.62

Price Performance

Historical Comparison
PNI
OKYO

About PNI Pimco New York Municipal Income Fund II of Beneficial Interest

PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. The fund's portfolio comprises investments across sectors such as education, transportation, healthcare, and others.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: